China 
Africa 
Explore chapters and articles related to this topic
Hospice vs. Palliative Care
Published in Inge B. Corless, Zelda Foster, The Hospice Heritage: Celebrating Our Future, 2020
Within the professional organizations of the health care groups involved in end-of-life care, there have been changes. The American Academy of Hospice Physicians is now the American Academy of Hospice and Palliative Medicine, and the Hospice Nursing Associa-tion is the Hospice and Palliative Nurse’s Association. The name changes indicate the awareness of the health care professional that in order to insure the principles of hospice care are maintained in health care delivery, they needed to reach out to a wider group of health care professionals. There are now certifications granted by both professional organizations.
Community, Public, and Professional Education
Published in Stephen R. Connor, Hospice and Palliative Care, 2017
The American Academy of Hospice and Palliative Medicine is an association of physicians working in hospice and palliative care. The academy holds a high-level annual clinical conference and has established training programs for hospice medical directors.
Predicting a “Lazarus Effect” in Patients With Advanced Cancer Near the End of Life: Prognostic Uncertainty, Oncologists’ Emotions, and Ethical Questions
Published in The American Journal of Bioethics, 2019
Chithra R. Perumalswami, Reshma Jagsi, Susan Dorr Goold
Patient factors that influence oncologists’ decisions around prescribing chemotherapy near death were also notable: some acknowledged chemotherapy may be used as a form of “palliation for emotional symptoms,” and others noted it could be used as “a means to preserve hope” (Bluhm et al. 2016, e1009). Patient wishes regarding the pursuit of treatment and also patient ability to weigh trade-offs were important patient-level factors identified in this and other studies. Speaking of the ability to weigh burdens and benefits in making decisions, one oncologist interviewed for a newsletter of the American Academy of Hospice and Palliative Medicine noted, “If there is even a 2% chance of a long-term remission with an immunologic, many patients and families are willing to take those odds, and I worry that more patients are spending their final moments undergoing aggressive therapy in the hospital and clinical setting rather than focusing on quality of the end of their life at home” (Roeland and LeBlanc 2017).